Celera Genomics and Celera Diagnostics to Webcast Investor Presentation.ROCKVILLE, Md. & ALAMEDA, Calif. -- Applera Corporation announced today that the Celera Genomics Group (NYSE NYSE See: New York Stock Exchange :CRA See Community Reinvestment Act. ) and Celera Diagnostics, a joint venture of Celera Genomics and Applera's Applied Biosystems Applied Biosystems, Inc. (formerly NASDAQ: ABIO) is the original name of a pioneer biotechnology company founded in 1981 in Foster City, California, among the Silicon Valley cities of the southern San Francisco Bay Area. Group (NYSE:ABI Abi (ā`bī) [short for Abijah], in the Bible, King Hezekiah's mother. (Application Binary Interface) A specification for a specific hardware platform combined with the operating system. ), will webcast a meeting with investors visiting Celera Diagnostics' Alameda offices on April 6, 2005. The meeting is scheduled to last from 9:00 a.m. PT to 11:00 a.m. PT. Kathy Ordonez, President of Celera Genomics and Celera Diagnostics, Robert Booth, Ph.D., Chief Scientific Officer of Celera Genomics, and Thomas White Thomas White can refer to:
Interested parties may access the live webcast and replay by visiting the Investors & Media section of either the Celera Genomics website at www.celera.com or the Applera website at www.applera.com or the Investors section of the Applied Biosystems website at http://ir.appliedbiosystems.com. It is suggested that participants access the webcast 15 minutes before the start of the live broadcast. The webcast replay will be archived on the Presentations page of the Investors & Media section of each website. About Applera Corporation Applera Corporation consists of two operating groups. The Celera Genomics Group is engaged principally in the discovery and development of targeted therapeutics for cancer, autoimmune and inflammatory diseases. Celera Genomics is leveraging its proteomic, bioinformatic, and genomic capabilities to identify and validate drug targets, and to discover and develop small molecule therapeutics. It is also seeking to advance therapeutic antibody and selected small molecule drug programs in collaboration with global technology and market leaders. The Applied Biosystems Group (NYSE:ABI) serves the life science industry and research community by developing and marketing instrument-based systems, consumables, software, and services. Customers use these tools to analyze nucleic acids Nucleic acids The cellular molecules DNA and RNA that act as coded instructions for the production of proteins and are copied for transmission of inherited traits. (DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. and RNA RNA: see nucleic acid. RNA in full ribonucleic acid One of the two main types of nucleic acid (the other being DNA), which functions in cellular protein synthesis in all living cells and replaces DNA as the carrier of genetic ), small molecules, and proteins to make scientific discoveries, develop new pharmaceuticals, and conduct standardized testing. Applied Biosystems is headquartered in Foster City, CA, and reported sales of $1.7 billion during fiscal 2004. Celera Diagnostics, a 50/50 joint venture between Applied Biosystems and Celera Genomics, is focused on discovery, development, and commercialization of diagnostic products. Information about Applera Corporation, including reports and other information filed by the company with the Securities and Exchange Commission, is available at www.applera.com, or by telephoning 800.762.6923. Information about Celera Genomics is available at www.celera.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion